FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Approves Cystadrops for Cystinosis Patients

[ Price : $8.95]

FDA approves Recordatis Cystadrops for reducing cystine crystal deposits in the cornea of the eye.

Dusa Paying $20.75 Million on FCA Allegations

[ Price : $8.95]

The Justice Department says Dusa will pay $20.75 million to resolve a whistleblowers charges that it induced doctors to file false...

FDA Panels to Review Reformulated Oxycontin Studies

[ Price : $8.95]

Federal Register notice: FDA announces a 9/10 joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anes...

Smiths Medical Recalls Medfusion Software

[ Price : $8.95]

Smiths Medical recalls specific software versions used with its Medfusion 3500 and 4000 Syringe Pumps because of an error that may...

House E&C Committee Wants Politics Out of Vaccine

[ Price : $8.95]

Leaders of the House Energy and Commerce Committee ask FDA commissioner Stephen Hahn what steps he is taking to ensure that scienc...

HCT/Ps Violations at 2 Banco Vida Facilities

[ Price : $8.95]

FDA warns Puerto Ricos Banco Vida Corp. about violations involving its umbilical cord blood products.

Wintac Warned on CGMP Inspection Violations

[ Price : $8.95]

FDA warns Wintac Limited about CGMP violations in its production of finished drugs at a facility in Bangalore, India.

Hahn has Mea Culpa Moment on Plasma Therapy Data

[ Price : $8.95]

FDA commissioner Stephen Hahn walks back his enthusiastic interpretation of data that supported the agencys recent decision to gra...

New Indication Sought for AbbVies Rinvoq

[ Price : $8.95]

AbbVie asks FDA to approve a new indication for Rinvoq to treat patients with active ankylosing spondylitis.

Gyroscope Therapeutics Orbit Subretinal Delivery Cleared

[ Price : $8.95]

FDA clears a Gyroscope Therapeutics 510(k) for the Orbit Subretinal Delivery System, indicated for microinjection into the subreti...